Accelerated Pharma

From Verify.Wiki
Jump to: navigation, search
Acceleratedpharma.jpg
apipharmaceuticals.com
Accelerated Pharma
Type Public
Industry Pharmaceutical
Founded 2014
Headquarters Burr Ridge, Illinois, United States
Key people Michael Fonstein (CEO), Randy S. Saluck J.D (CFO), Ekaterina Nikolaevskaya (COO), Dmitry Prudnikov (Chief Medical Officer) [1]
Number of employees 7 [2]

Accelerated Pharma, Inc., a clinical stage pharmaceutical company, focuses on the development of pharmaceutical products for the treatment of various cancer indications. [3] It has a potential blockbuster cancer drug, Picoplatin, which is progressing towards Phase II trials. Picoplatin is a next generation platinum-based chemotherapy that may offer significant improvement over current standards of care.
It has received around $250k Debt Financing on May 4, 2016 and filed an IPO with plans to raise $17 million by offering 1.9 million shares at a price range of $8 to $10 [4]

Products

Picoplatin is their lead product. Its exclusive features are:

  • The company’s first acquisition is Picoplatin
  • Picoplatin has the potential for use in different formulations
  • It can work as a single agent or in combination with other anti-cancer agents
  • It works to treat multiple cancer indications.
  • More then 20 clinical trials with Picoplatin in approximately a thousand cancer patients have been performed up to date.
  • The company holds an exclusive, worldwide licensee of patented and proprietary technology related to Picoplatin.
  • The company intends to further develop these drugs through multi-national trials under the guidance of both the FDA and foreign regulatory agencies

[5]

Controversies

None Reported

Top 5 Recent Tweets

DateAuthorComment
April 21, 2021bagelrhodesLearn about the advantages of using an accelerated compute framework using DeepVariant tools for industrial genomic… https://t.co/G9FoEbT4Wz
April 21, 2021prmaconsultingMarket access case study >> https://t.co/N5ZhA2MUeG How a top-5 #pharma company accelerated the generation of HTA s… https://t.co/9fDy7xpUfV
April 21, 2021QMENTA_IncWe're thrilled to have Chris Llewellyn, Senior Partner, @McKinsey as a speaker in May. Spurred by the pandemic, inn… https://t.co/LwwQKXikUs
April 21, 2021RealTimeCTMSCovid-19 has accelerated decentralized trials creating opportunities to improve patient engagement, costs, and data… https://t.co/w7PFOj0AUL


Top 5 Recent News Headlines

  • Cancer therapies accelerate: Accelerated Pharma files and sets terms for $17 million IPO - The Westport, CT-based company plans to raise $17 million by offering 1.9 million shares at a price range of $8 to $10. [6]
  • AzurRX discounts $5M IPO as Accelerated Pharma files for $17M offering -AzurRX gets off its IPO, but at a downsized offering, while Accelerated Pharma hopes to get off its proposed $17 million offering. [7]
  • BRIEF-Accelerated Pharma files for IPO of up to $36.7 mln - Accelerated Pharma - Applied To Have Common Stock Listed On The Nasdaq Capital Market Under The Symbol "ACCP". [8]
  • Accelerated Pharma Announces Expected Price Range for IPO - At the maximum price, the entire offering is valued up to $21.72 million. The company intends to list its shares on the Nasdaq under the symbol ACCP. [9]
  • Accelerated pharma services approach in Russia - The pharma industry in Russia is one of the most rapidly developing markets, and in the last two decades, many companies built new facilities and reconstructed existing plants.[10]

References

  1. http://apipharmaceuticals.com/?page_id=156
  2. http://www.nasdaq.com/markets/ipos/company/accelerated-pharma-inc-955237-81871
  3. https://www.crunchbase.com/organization/accelerated-pharma#/entity
  4. http://www.nasdaq.com/article/cancer-therapies-accelerate-accelerated-pharma-files-and-sets-terms-for-17-million-ipo-cm692120#ixzz4OD4u1PNw
  5. http://www.nasdaq.com/markets/ipos/company/accelerated-pharma-inc-955237-81871#ixzz4OD8fSqXY
  6. http://www.nasdaq.com/article/cancer-therapies-accelerate-accelerated-pharma-files-and-sets-terms-for-17-million-ipo-cm692120#ixzz4OD7ij5R2
  7. http://www.fiercebiotech.com/biotech/azurrx-biopharma-discounts-5m-ipo-as-accelerated-pharma-files-for-19m-offering
  8. http://www.reuters.com/article/idUSFWN1CH107
  9. https://www.yahoo.com/news/accelerated-pharma-announces-expected-price-114526558.html
  10. http://www.tebodin.bilfinger.com/eastern-europe/news/articles/accelerated-pharma-services-approach-in-russia/

Verification history